Stage iv breast cancer Trials in Indianapolis, United States
Conditions / Stage iv breast cancer / Indianapolis, United States
Stage iv breast cancer is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02457910 | Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer | TERMINATED | PHASE1/PHASE2 |
| NCT01242800 | Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer | COMPLETED | NA |
| NCT03206203 | Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer | COMPLETED | PHASE2 |
| NCT01307891 | Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer | COMPLETED | PHASE2 |
| NCT01918306 | GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer | TERMINATED | PHASE1/PHASE2 |
| NCT01881230 | Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) | COMPLETED | PHASE2/PHASE3 |
| NCT02206334 | Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer | COMPLETED | PHASE1 |
| NCT00577122 | Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer | COMPLETED | PHASE2 |
| NCT01124695 | Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer | COMPLETED | PHASE2 |
| NCT00520975 | Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU | TERMINATED | PHASE3 |